Mexico strengthens medtech and health ties with UK
This article was originally published in Clinica
Visiting senior staff of the UK's National Institute for Clinical Excellence (NICE) was among the priorities of a recent visit by the Mexican health ministry to London. Health minister Julio Frenk Mora met with NICE executive director Andrew Dillon to discuss the institute's experience in the field of health technology assessment and health service guidance.
You may also be interested in...
The French major and Regeneron have racked up another indication for Dupixent with the blockbuster getting approval in Europe to treat children with severe eczema.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
Russia says it will make the first deliveries of its $10-per-dose Sputnik V vaccine in January, while international regulators say vaccine trials should continue for as long as possible to generate longer-term evidence on their benefits and risks. A UK research body has stressed that drugs repurposed for COVID-19 also need to undergo thorough safety and efficacy testing as reports suggest the UK regulator could approve a vaccine within days.